April 11, 2021

Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact through the CREB1 protein

Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new

Patients with non-small cell lung cancer (NSCLC) whose cancer cells have low levels of aneuploidy—an abnormal number of chromosomes—tend to respond better to immune checkpoint inhibitor drugs than patients with

A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and

Thailand’s Health Ministry warned Sunday that restrictions may need to be tightened to slow the spread of a fresh coronavirus wave, as the country hit a daily record for new

April is shaping up to be Brazil’s darkest month yet in the pandemic, with hospitals struggling with a crush of patients, deaths on track for record highs and few signs